Live from the NIH registry
Studies recruiting near Canton right now
Top 25 of 305 recruiting studies, sorted by proximity — each links to its official registry page
The Pediatric Anesthesia Quality Improvement Project
Surgery, Anesthesia
N/A
Observational 5,000,000 participants sought
Akron Children's Hospital — Akron, Ohio (20.5 mi)
· Sponsor: The Society for Pediatric Anesthesia
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Cleveland Clinic Mercy Hospital — Canton, Ohio (0.8 mi)
· Sponsor: SWOG Cancer Research Network
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Cleveland Clinic Wooster Family Health and Surgery Center — Wooster, Ohio (29.8 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.
Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma
Phase 1
Interventional 168 participants sought
Gabrail Cancer Center Research — Canton, Ohio (0.8 mi)
· Sponsor: OncoNano Medicine, Inc.
Investigations of Reproductive Cancers in Women
Uterine Cancer
N/A
Observational 4,500 participants sought
Summa Health — Akron, Ohio (20.5 mi)
· Sponsor: PinkDx, Inc.
A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
PARKINSON DISEASE (Disorder)
Phase 2
Interventional 80 participants sought
Vima Site #051 — Canton, Ohio (0.8 mi)
· Sponsor: Vima Therapeutics
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
Focal Segmental Glomerulosclerosis
N/A
Interventional 35 participants sought
Akron Children's Hospital — Akron, Ohio (20.5 mi)
· Sponsor: Kaneka Medical America LLC
C-Brace Prospective Registry
Pareses, Lower Extremity
N/A
Observational 250 participants sought
Yanke Bionics - W Exchange St — Akron, Ohio (20.5 mi)
· Sponsor: Otto Bock Healthcare Products GmbH
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
Graves' Disease
Phase 2
Interventional 240 participants sought
Site Number - 1057 — Canton, Ohio (0.8 mi)
· Sponsor: Immunovant Sciences GmbH
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
Phase 4
Interventional 6,000 participants sought
Aultman Hospital — Canton, Ohio (0.8 mi)
· Sponsor: Duke University
Yoga for Black and Brown Women Who Have Experienced Abuse From an Intimate Partner
Intimate Partner Violence (IPV), Psychological Well Being
Phase 1
Interventional 40 participants sought
the University of Akron — Akron, Ohio (20.5 mi)
· Sponsor: The University of Akron
A Study to Learn About How 20-Valent Pneumococcal Conjugate Vaccine Works in a Real-world Setting
Pneumonia
N/A
Observational 12,500 participants sought
Summa Health Clinical Research Center - Specialty — Akron, Ohio (20.5 mi)
· Sponsor: Pfizer
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
Colonic Neoplasms, Neoplasms, Colon
Phase 3
Interventional 892 participants sought
GSK Investigational Site — Akron, Ohio (20.5 mi)
· Sponsor: GlaxoSmithKline
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,209 participants sought
Cleveland Clinic Mercy Hospital — Canton, Ohio (0.8 mi)
· Sponsor: NRG Oncology
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
Leukemia, Myeloid, Acute
Phase 3
Interventional 600 participants sought
Gabrail Cancer Center — Canton, Ohio (0.8 mi)
· Sponsor: Janssen Research & Development, LLC
Post Approval Study for Treatment of Drug-resistant Adult and Pediatric Primary FSGS Using the LIPOSORBER® LA-15 System
Focal Segmental Glomerulosclerosis
N/A
Interventional 35 participants sought
Akron Children's Hospital — Akron, Ohio (20.5 mi)
· Sponsor: Kaneka Medical America LLC
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma
Phase 3
Interventional 1,450 participants sought
University Hospitals Sharon Health Center — Wadsworth, Ohio (24.2 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
INTREPID: A Study of Sapablursen Evaluating the Safety and Efficacy in Participants With Polycythemia Vera (PV)
Polycythemia Vera
Phase 3
Interventional 250 participants sought
Gabrail Cancer Center Research — Canton, Ohio (0.8 mi)
· Sponsor: Ono Pharmaceutical Co., Ltd.
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
Childhood Medulloblastoma
Phase 3
Interventional 225 participants sought
Children's Hospital Medical Center of Akron — Akron, Ohio (20.5 mi)
· Sponsor: Children's Oncology Group
Stepped Approach to Reducing Risk of Suicide in Primary Care
Suicidal Ideation, Suicide, Attempted
N/A
Interventional 2,572 participants sought
AxessPointe Community Health Centers/Health Quarters — Akron, Ohio (20.5 mi)
· Sponsor: Cynthia Fontanella
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Hypothyroidism
Phase 2, Phase 3
Interventional 2,800 participants sought
Diabetes and Endocrinology Associates of Stark County Inc /ID# 256751 — Canton, Ohio (0.8 mi)
· Sponsor: AbbVie
Study of SGR-1505 in Mature B-Cell Neoplasms
Mature B-Cell Neoplasm, Non Hodgkin Lymphoma
Phase 1
Interventional 98 participants sought
Gabrail Cancer & Research Center — Canton, Ohio (0.8 mi)
· Sponsor: Schrödinger, Inc.
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Breast Cancer
Phase 3
Interventional 3,960 participants sought
Aultman Health Foundation — Canton, Ohio (0.8 mi)
· Sponsor: NRG Oncology
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Heart Failure, Acute Heart Failure
Phase 3
Interventional 5,200 participants sought
Akron, OH Investigative Site 10081 — Akron, Ohio (20.5 mi)
· Sponsor: Colorado Prevention Center
A Study to Evaluate the Effect of Obicetrapib/Ezetimibe 10 mg Fixed-Dose Combination or Obicetrapib 10 mg Daily on Top of Guideline-Recommended Lipid-Lowering Therapy in Participants With Type 2 Diabetes and/or Metabolic Syndrome
Lipidemia, Type 2 Diabetes (T2DM)
Phase 3
Interventional 300 participants sought
Summit Research Group — Munroe Falls, Ohio (23.6 mi)
· Sponsor: NewAmsterdam Pharma